Beat Street: Hovnanian and PDL BioPharma (NYSE:HOV),(NASDAQ:PDLI)


Hovnanian Enterprises, Inc. (NYSE:HOV) posts Fiscal Q1 EPS of $2.97, although it may not be comparable to consensus of -$0.45 since as a result of tax legislation changes, the after-tax net income included a federal income tax benefit of $291.3 million.

Syndicate content

WallStNation.comThanks for visiting, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.

To Browse our Most Recent Stories (click here)

Share Content

Share this article with others, is the Independent Wall Street Newspaper. Thanks for Reading!

Daily Market Summary

Please Review the Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details